Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 316

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 316
---
  Forfeited                                                                        ( 218,892         $5.38                                                
  Outstanding at end of period                                                    14,449,650         $4.62      $                        2,964      6.92  
  Exercisable options                                                              9,563,187         $4.81      $                        2,430      6.15  

The weighted-average
grant date fair value of options granted during the years ended December 31, 2022, 2023 and 2024, was $3.76, $1.87and $1.43, respectively.

The weighted average
exercise price of the Company’s options granted during the years ended December 31, 2022, 2023 and 2024 was $8.08, $3.47and $3.60, respectively.

The total intrinsic
value of options exercised during the years ended December 31, 2022 and 2023 was $120and $79, respectively.

A summary of the
status of RSUs under the Plan as of December 31, 2024 and changes during the relevant period ended on that date is presented below:

                                        RSUs                                                
                                        Unvested RSUs                     Weighted-average  
  Outstanding at beginning of year                           813,268                 $5.68  
  Granted                                                    796,127                 $2.88  
  Vested                                                   ( 687,356                 $4.50  
  Forfeited                                                 ( 64,140                 $3.84  
  Outstanding at end of year                                 857,899                 $4.24  

The weighted-average
grant date fair value of RSUs granted during the years ended December 31, 2022 and 2023 was $9.01and $3.36, respectively. The total fair
value of RSUs, as of their respective release dates, was $347, $1,644and $1,910during the years ended December 31, 2022, 2023, and 2024,
respectively.

F-26

ALPHA TAU MEDICAL
LTD. AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS

U. S. dollars
in thousands (except share and per share data)

NOTE 12:- SHAREHOLDERS’ (DEFICIENCY) EQUITY (Cont.)

The total equity-based
compensation expense related to all of the